Zusammenfassung
Funktionelle Sexualstörungen sind Störungen der sexuelle Appetenz (Libido), der sexuellen Erregung, des Orgasmus und der Befriedigung. Die Häufigkeit sexueller Funktionsstörungen wird in der Literatur entsprechend der Erhebungsmethode und dem Jahr der Erhebung unterschiedlich angegeben. Meist wurde eine spezielle Klientel an Patientinnen von Spezialsprechsunden oder Schätzzahlen ausgewertet. Für die tägliche Arbeit in gynäkologischen Praxen und Kliniken sind die Häufigkeiten aus Durchschnittspopulationen entscheidend.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ahrendt HJ, Friedrich C (2010) Prävention und Therapie sexueller Störungen. JFrauengesundheit Z Frauenärztl Prax 1: 11–26
Ahrendt HJ, Friedrich C (2011a) Häufigkeit sexueller Fragen und Probleme in der gynäkologischen Sprechstunde Frauenarzt 52, 6
Ahrendt HJ, Friedrich C (2011b) Zur Situation der Ausbildung in Sexualmedizin. Frauenarzt 52, 8
Ahrendt HJ, Friedrich C, Dreyer P (2010) Sexualität in der Schwangerschaft und post partum. Konsequenzen für die Praxis. Gynäkol Geburtsh Gynäkol Endokrinol
Ahrendt HJ, Adolf, D, Friedrich C (2011) Inzidenz sexueller Probleme in der gynäkologischen Praxis. Sexuologie 18 (1-2): 25–29
Alexander JL, Dennerstein L, Burger H, Graziottin A (2006) Testosterone and libido in surgically and naturally menopausal women. Women's Health 2 (3): 459–477
Basson R et al. (2000) Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 163: 888–893
Basson, R, Mcinnes R, Schmith M et al. (2002) Efficacy and safety of sildefanil in women with sexual dysfunction associated with female sexual arousal disorder. J Women's Health Gend Based Med 11: 367
Basson R, Weijmar Schultz W, Binik Y, Eschenbach D, Wesselmann U, Van Lankveld J (2005) Women's sexual pain and its management. J Sexual Med 2 (3): 301–316
Basson R, Weijmar Schultz WCM, Binik YM, Brotto LA, Eschenbach DA et al. (2005) Women's sexual desire and arousal disorders and sexual pain. In: Lue TF, Basson R, Rosen R et al. (eds) Sexual medicine: Sexual pain and its management. Paris: Health Publications 2004; 937–946
Beier KM, Bosinski H, Loewit K, Sohn M, Peek A (2005) Geschlechtsidentitätsstörungen. In: Beier KM, Bosinski H, Loewit K (Hrsg) Sexualmedizin. München Jena: Urban & Fischer, S 365–412
Berman JR. Berman LA. Toler TM et al. (2003a) Safety and efficacy of sildenafil for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study. J Urol 170: 2333
Berman L, Berman J, Felder S et al. (2003b) Seeking help for sexual function complaints: what gynecologists need to know about the female patient's experience. Fertil Steril 79 (3): 572–576
Biglia N, Maffei S, Lello S, Nappi RE (2010) Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials. Gynecol Endocrinol 26 (11): 804–814
Bitzer J (2008) Die sexuelle Dysfunktion der Frau – Ursachen und aktuelle Therapieoptionen. Bremen London Bosten: Uni-Med Verlag
Braunstein GD (2002) Androgen insufficiency in women: summary of critical issues. Fertil Steril 77: 94–99
Buster JE, Kingsberg, SA, Aguirre O et al. (2005) Testosterone patch for low sexual desire in surgicalla menopausal women: a randomized trial. Obstet Gynecol 105: 944–952
Caruso S, Sareri MI, Agnello C et al (2011) Conventional versus extended- cycle oral contraceptives on the quality of sexual life: Comparison between two regimens containing 3 mg drospirenone and 20 mg ethinyl estradiol. J Sex Med 8: 1478–1485
Castello-Branco C, Vicente JJ, Figueras F et al. (2000) Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas 34: 161
Coenan C, Thomas C, Borm G, Hollanders, Rolland R (1996) Changes in androgen during treatment with four low dose contraceptives. Contraception 53: 171–176
Davis SR, Mccloud P, Strauss BJ, Burger H (1995) Testosterone erhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 21 (3): 227–236
Dew JE, Wren BG, Eden JA (2003) A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer. Climateric 6: 45–52
Doeren M, Ruebig A, Coelingh Bennink HJT, Holzgreve W (2001) Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. Fertil Steril 75: 554–59
Dowsett M, Folkerd E (2005) Deficits in plasma oestradiol measurement in studies and management of breast cancer. Breast Cancer Res 7: 1–4
Elauta E, Buysse A, de Sutter P et al. (2011) Relation of androgen receptor sensitivity and mood to sexual desire in hormonal contraception users. Contraception 85, 5: 470–479
Ferguson DM (2003) Randomized, placebo-controlled, double blind, crossover design trial of the efficacy and safety of Zestra for women in women with and without female sexual arousal disorder. J Sex Marital Ther 29 Suppl 1: 33–38
Ginzburg R, Wong Y, Fader JS (2005) Effect of bupropion on sexual dysfunction. Ann Pharmacother 39: 2096–2099
Goldstein I, Lines C, Pyke R, Scheld JS (2009) National differences in patient-clinician communication regarding hypoactive sexual desire disorder. J Sexual Med 6: 1349–1357
Gooyer De M, Deckers G, Schoonen W, Verheul H, Kloosterboer H (2003) Receptor profiling and endocrine interactions of tibolone. Steroids 68: 21–30
Graziottin A (2003) Etiology and diagnosis of coital pain. J Endocrinol Invest [Suppl 3] 26: 115–121
Gregersen N et al. (2006) Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication. Dan Med Bull 2006
Gudermann T (2009) Endokrinopharmakologie. In: Leidenberger F, Strowitzki T, Ortmann O (Hrsg) Klinische Endokrinologie für Frauenärzte, 4. Aufl. Berlin Heidelberg New York: Springererlag Heidelberg
Guillermo et al. (2010) Female social and sexual interest across the menstrual cycle: the roles of pain, sleep and hormones BMC Women's Health 10: 19
Hartmann U (2008) Es besteht großer Handlungsbedarf. Gyne 03/2008: 49–58
Hartmann U, Philippsohn S (2008) Wie sollte bei sexuellen Schmerzstörungen in praxi vorgegangen werden. Gyne 08/2008 209–216
Hunt PJ, Gurnell EM, Huppert FA et al. (2000) Original Studys-Inprovement in Mood and Fatigue after Dehydroepiandrosterone, Replacement in Addision´s Desease in a Randomized, Double Blind Trial, J Clin Endocrinol and Metab 85: 4650–4656
Kovalevsky G (2005) Female sexual dysfunction and use of hormone therapy in postmenopausal women. Semin Reprod Med 23 (2): 180–187
Kuhl H, Taubert HD (1987) Das Klimakterium. Pathephysiologie, Klinik, Therapie. Stuttgart New York: Thieme
Laumann EO, Paik A, Rosen RC (1999) Sexual dysfunction in the United States: Prevalence and predictors. JAMA 281:Lovas K, Gebre- Medhin G, Trovik TS et al. (2003) Endocrine care – of special interest to the practice of endocrinology. Replacement of dehydroepiandrosterone in adrenal failure: No benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial.J Clin Endocrinol Metab 88: 1112
Masters WH, Johnson VE (1970) Die sexuelle Reaktion. Reinbek: Rowohlt
Morales AJ, Nolan JJ, Nelson JC, Yen SSC (1994) Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78: 1360
Nappi R, Dean J, van Lunsen H et al. (2009) Efficacy of flibanserin as a potential treatment for hypoactive sexual desire disorder in European pre-menopausal women: results from the ORCHID trial. Abstract accepted to the European SocietySarrel P, Dobay B, Wiita B (1998) Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses. J Reprod Med 43: 847
Nappi RE, Davis SR, Parke S et al. (2011) Effects of estradiol valerate/ dienogest compared with ethinylestradiol/levonorgestrel on libido. Endocrin Rev 32:1–315
Nika E, Briken P (2000) Die Anwendung von Viagra bei Frauen- Eine kasuistische Beschreibung von fünf Frauen. Sexuologie 7 (4): 223–232
Ott MA et al. (2008) The influence of hormonal contraception on mood and sexual interest among adolescents. Arch Sex Behav 37 (4): 605–613
Palacios S, Menendez C, Jurado AR, Castano R, Vargas JC (1995) Changes in sex behaviour after menopause: Effects of tibolone. Maturitas 22: 155–161
Segraves R, Taylor MD, Clayton A et al. (2004) Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol 24: 339
Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S (2005) Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 90 (9): 5226–5233
Skrzypulec V, Drosdzol A (2008) Evaluation of the quality of life and sexual functioning of women using a 30ug ethinyloestradiol and 3mg dorpirenone combined oral contraceptive. Eur Contracept Reprod Health Care 13: 49–57
Sonboonporn W, Davis S, Seif MW, Bell R (2005) Testosterone for periand postmenopausal women. Cochrane Database Syst Rev 4: CD004509
Speroff L, Glass RH, Kase NG (eds) (1999) Clinical gynaecologic endocrinology and infertility, 6th edn. Philadelphia: Lippincott Williams & Wilkins, pp 31–105
Steinberg AC, Oyama IA, Rejba AE, Kellogg-Spadt S, Withmore KE (2005) Capsaicin for the treatment of vular vestibulitis. Am J Obstet Gynecol (2005) 192: 1549–1553
Suckling J, Lethaby A, Kennedy R (2003/2005) Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 4: CD001500
Valk M (2009) Tipps für die Gesprächsführung in der Praxis. Beilage in Frauenarzt 50, 12
Victor A, Weiner E, Johansson ED (1976) Sex hormone binding globulin. The carrier protein for d-norgestrel. J Clin Endocrinol Metab 43: 244
Wallwiener M, Wallwiener LM, Seeger A et al. (2010) Effects of sex hormones in oral contraceptives on the female sexual function score: a study in German female medical students. Contraception 82, 2: 155–159
Warner P, Bancroft J (1988) Mood, sexuality, oral contraceptive and the menstrual cyde. Psychosom Res 32: 417–427
Weijmar Schultz W, Basson R, Binik Y, Eschenbach D, Wesselmann U, Van Lankveld J (2005) Women's sexual pain and its management. J Sexual Med 2 (3): 301–316
Wylie KR (2006) Sexuality and the menopause. J Br Menopause Soc 12 (4): 149–152
Yen SSC (1999) In: Yen SSC, Jaffe RB, Barbieri RL (eds) Reproductive endocrinology: physiology, pathophysiology and clinical management, 4th edn. Philadelphia: Saunders, pp 1999; 479–515
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ahrendt, HJ., Friedrich, C. (2013). Sexuelle Funktionsstörungen der Frau: Diagnostik, Therapie. In: Kaufmann, M., Costa, S.D., Scharl, A. (eds) Die Gynäkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20923-9_57
Download citation
DOI: https://doi.org/10.1007/978-3-642-20923-9_57
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-20922-2
Online ISBN: 978-3-642-20923-9
eBook Packages: Medicine (German Language)